{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:58:18Z","timestamp":1776995898006,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JP16K09608"],"award-info":[{"award-number":["JP16K09608"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007638","name":"The Kidney Foundation, Japan","doi-asserted-by":"crossref","award":["JKFB17-3"],"award-info":[{"award-number":["JKFB17-3"]}],"id":[{"id":"10.13039\/501100007638","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10157-019-01787-6","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T08:02:57Z","timestamp":1568016177000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Relationship between anti-erythropoietin receptor autoantibodies and responsiveness to erythropoiesis-stimulating agents in patients on hemodialysis: a multi-center cross-sectional study"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0399-1474","authenticated-orcid":false,"given":"Akinori","family":"Hara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Koshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukie","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taito","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Furuichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,9]]},"reference":[{"key":"1787_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/ndt\/17.suppl_11.39","volume":"17","author":"IC Macdougall","year":"2002","unstructured":"Macdougall IC, Cooper AC. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2002;17:39\u2013433.","journal-title":"Nephrol Dial Transplant"},{"key":"1787_CR2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.ajkd.2016.05.031","volume":"68","author":"J Luo","year":"2016","unstructured":"Luo J, Jensen DE, Maroni BJ, Brunelli SM. Spectrum and burden of erythropoiesis-stimulating agent hyporesponsiveness among contemporary hemodialysis patients. Am J Kidney Dis. 2016;68:763\u201371.","journal-title":"Am J Kidney Dis"},{"key":"1787_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41100-017-0114-y","volume":"3","author":"H Yamamoto","year":"2017","unstructured":"Yamamoto H, Nishi S, Tomo T, Masakane I, Saito K, Nangaku M, et al. 2015 Japanese Society for dialysis therapy: guidelines for renal anemia in chronic kidney disease. Renal Replace Ther. 2017;3:36.","journal-title":"Renal Replace Ther"},{"key":"1787_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/kisup.2012.35","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO. Chapter 3: use of ESAs and other agents to treat anemia in CKD. Kidney Int Suppl. 2012;2:299\u2013310.","journal-title":"Kidney Int Suppl"},{"key":"1787_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/bjh.12105","volume":"160","author":"A Hara","year":"2013","unstructured":"Hara A, Furuichi K, Higuchi M, Iwata Y, Sakai N, Kaneko S, et al. Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia. Br J Haematol. 2013;160:244\u201350.","journal-title":"Br J Haematol"},{"key":"1787_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/nep.12641","volume":"20","author":"K Koibuchi","year":"2015","unstructured":"Koibuchi K, Miyagi M, Arai T, Aoki T, Aikawa A, Sakai K. Comparing the efficacy of continuous erythropoietin receptor activator and darbepoetin Alfa treatments in Japanese patients with chronic kidney disease during the predialysis period: a propensity-matched analysis. Nephrology. 2015;20:22\u20138.","journal-title":"Nephrology"},{"key":"1787_CR7","first-page":"411","volume":"12","author":"JT Daugirdas","year":"1989","unstructured":"Daugirdas JT. The post: pre-dialysis plasma urea nitrogen ratio to estimate K.t\/V and NPCR: mathematical modeling. Int J Artif Organs. 1989;12:411\u20139.","journal-title":"Int J Artif Organs"},{"key":"1787_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s10157-018-1569-z","volume":"22","author":"T Okamoto","year":"2018","unstructured":"Okamoto T, Hatakeyama S, Tanaka Y, Imanishi K, Takashima T, Saitoh F, et al. Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study. Clin Exp Nephrol. 2018;22:1174\u201381.","journal-title":"Clin Exp Nephrol"},{"key":"1787_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0140-6736(05)60259-0","volume":"352","author":"A Schwarzbeck","year":"1998","unstructured":"Schwarzbeck A, Wittenmeier KW, H\u00e4llfritzsch U. Anaemia in dialysis patients as a side-effect of sartanes. Lancet. 1998;352:286.","journal-title":"Lancet"},{"key":"1787_CR10","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3899\/jrheum.151430","volume":"43","author":"A Hara","year":"2016","unstructured":"Hara A, Furuichi K, Yamahana J, Yasuda H, Iwata Y, Sakai N, et al. Effect of autoantibodies to erythropoietin receptor in systemic lupus erythematosus with biopsy-proven lupus nephritis. J Rheumatol. 2016;43:1328\u201334.","journal-title":"J Rheumatol"},{"key":"1787_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ekir.2017.08.017","volume":"3","author":"A Hara","year":"2017","unstructured":"Hara A, Furuichi K, Koshino A, Yasuda H, Tran T, Iwata Y, et al. Clinical and pathological significance of autoantibodies to erythropoietin receptor in type 2 diabetic patients with CKD. Kidney Int Rep. 2017;3:133\u201341.","journal-title":"Kidney Int Rep"},{"key":"1787_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/ndt\/gfn543","volume":"24","author":"BD Bradbury","year":"2009","unstructured":"Bradbury BD, Critchlow CW, Weir MR, Stewart R, Krishnan M, Hakim RH. Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients. Nephrol Dial Transplant. 2009;24:919\u201325.","journal-title":"Nephrol Dial Transplant"},{"key":"1787_CR13","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1093\/ndt\/gfs368","volume":"28","author":"M Rattanasompattikul","year":"2013","unstructured":"Rattanasompattikul M, Molnar MZ, Zaritsky JJ, Hatamizadeh P, Jing J, Norris KC, et al. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients. Nephrol Dial Transplant. 2013;28:1936\u201345.","journal-title":"Nephrol Dial Transplant"},{"key":"1787_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3945\/ajcn.113.062802","volume":"99","author":"Y Chen","year":"2014","unstructured":"Chen Y, Abbate M, Tang L, Cai G, Gong Z, Wei R, et al. L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis. Am J Clin Nutr. 2014;99:408\u201322.","journal-title":"Am J Clin Nutr"},{"key":"1787_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/MCO.0b013e32830f2256","volume":"11","author":"HK Biesalski","year":"2008","unstructured":"Biesalski HK. Parenteral ascorbic acid in haemodialysis patients. Curr Opin Clin Nutr Metab Care. 2008;11:741\u20136.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1787_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11255-012-0175-3","volume":"45","author":"A Rusu","year":"2013","unstructured":"Rusu A, Rusu F, Zalutchi D, Muresan A, Gherman Caprioara M, Kacso I. The influence of vitamin E supplementation on erythropoietin responsiveness in chronic hemodialysis patients with low levels of erythrocyte superoxide dismutase. Int Urol Nephrol. 2013;45:495\u2013501.","journal-title":"Int Urol Nephrol"},{"key":"1787_CR17","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.3390\/nu7053783","volume":"7","author":"H Kobayashi","year":"2015","unstructured":"Kobayashi H, Abe M, Okada K, Tei R, Maruyama N, Kikuchi F, et al. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis. Nutrients. 2015;7:3783\u201395.","journal-title":"Nutrients"},{"key":"1787_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2169\/internalmedicine.45.1541","volume":"45","author":"T Higuchi","year":"2006","unstructured":"Higuchi T, Matsukawa Y, Okada K, Oikawa O, Yamazaki T, Ohnishi Y, et al. Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia. Intern Med. 2006;45:271\u20133.","journal-title":"Intern Med"},{"key":"1787_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/00365519609088642","volume":"224","author":"BM Altura","year":"1996","unstructured":"Altura BM, Altura BT. Role of magnesium in patho-physiological processes and the clinical utility of magnesium ion selective electrodes. Scand J Clin Lab Investig Suppl. 1996;224:211\u201334.","journal-title":"Scand J Clin Lab Investig Suppl"},{"key":"1787_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/ki.2013.327","volume":"85","author":"Y Sakaguchi","year":"2014","unstructured":"Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014;85:174\u201381.","journal-title":"Kidney Int"},{"key":"1787_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1159\/000189414","volume":"74","author":"A Allegra","year":"1996","unstructured":"Allegra A, Corica F, Ientile R, Naso A, Corsonello A, Montalto G, et al. Effect of intravenous recombinant erythropoietin administration on plasma and erythrocyte magnesium concentrations in patients on hemodialysis. Nephron. 1996;74:499\u2013500.","journal-title":"Nephron"},{"key":"1787_CR22","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/ki.2012.270","volume":"82","author":"TB Dr\u00fceke","year":"2012","unstructured":"Dr\u00fceke TB, Parfrey PS. Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s). Kidney Int. 2012;82:952\u201360.","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01787-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-019-01787-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01787-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T23:49:19Z","timestamp":1599522559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-019-01787-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1787"],"URL":"https:\/\/doi.org\/10.1007\/s10157-019-01787-6","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,9]]},"assertion":[{"value":"5 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in studies involving human participants were in accordance with the ethical standards of the medical ethics committee of Kanazawa University at which the studies were conducted (approval number 1590) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}